Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA39581
Max Phase: Preclinical
Molecular Formula: C15H13NO2S
Molecular Weight: 271.34
Molecule Type: Small molecule
Associated Items:
ID: ALA39581
Max Phase: Preclinical
Molecular Formula: C15H13NO2S
Molecular Weight: 271.34
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 4-Phenoxyphenoxyethyl Thiocyanate
Synonyms from Alternative Forms(1):
Canonical SMILES: N#CSCCOc1ccc(Oc2ccccc2)cc1
Standard InChI: InChI=1S/C15H13NO2S/c16-12-19-11-10-17-13-6-8-15(9-7-13)18-14-4-2-1-3-5-14/h1-9H,10-11H2
Standard InChI Key: YQZHGQYIMXWEHI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 271.34 | Molecular Weight (Monoisotopic): 271.0667 | AlogP: 4.07 | #Rotatable Bonds: 6 |
Polar Surface Area: 42.25 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.78 | CX LogD: 3.78 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.59 | Np Likeness Score: -0.82 |
1. Cinque GM, Szajnman SH, Zhong L, Docampo R, Schvartzapel AJ, Rodriguez JB, Gros EG.. (1998) Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi., 41 (9): [PMID:9554887] [10.1021/jm970860z] |
2. Szajnman SH, Yan W, Bailey BN, Docampo R, Elhalem E, Rodriguez JB.. (2000) Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation., 43 (9): [PMID:10794699] [10.1021/jm9905007] |
3. Elhalem E, Bailey BN, Docampo R, Ujváry I, Szajnman SH, Rodriguez JB.. (2002) Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi., 45 (18): [PMID:12190320] [10.1021/jm0201518] |
4. Szajnman SH, Bailey BN, Docampo R, Rodriguez JB.. (2001) Bisphosphonates derived from fatty acids are potent growth inhibitors of Trypanosoma cruzi., 11 (6): [PMID:11277521] [10.1016/s0960-894x(01)00057-9] |
5. Szajnman SH, Ravaschino EL, Docampo R, Rodriguez JB.. (2005) Synthesis and biological evaluation of 1-amino-1,1-bisphosphonates derived from fatty acids against Trypanosoma cruzi targeting farnesyl pyrophosphate synthase., 15 (21): [PMID:16143525] [10.1016/j.bmcl.2005.07.060] |
6. Ravaschino EL, Docampo R, Rodriguez JB.. (2006) Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis., 49 (1): [PMID:16392828] [10.1021/jm050922i] |
7. Liñares GG, Gismondi S, Codesido NO, Moreno SN, Docampo R, Rodriguez JB.. (2007) Fluorine-containing aryloxyethyl thiocyanate derivatives are potent inhibitors of Trypanosoma cruzi and Toxoplasma gondii proliferation., 17 (18): [PMID:17643987] [10.1016/j.bmcl.2007.07.012] |
8. Szajnman SH, García Liñares GE, Li ZH, Jiang C, Galizzi M, Bontempi EJ, Ferella M, Moreno SN, Docampo R, Rodriguez JB.. (2008) Synthesis and biological evaluation of 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase., 16 (6): [PMID:18096393] [10.1016/j.bmc.2007.12.010] |
9. Prado-Prado FJ, García-Mera X, González-Díaz H.. (2010) Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species., 18 (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068] |
10. Lin FY, Liu YL, Li K, Cao R, Zhu W, Axelson J, Pang R, Oldfield E.. (2012) Head-to-head prenyl tranferases: anti-infective drug targets., 55 (9): [PMID:22486710] [10.1021/jm300208p] |
11. Elicio PD, Chao MN, Galizzi M, Li C, Szajnman SH, Docampo R, Moreno SN, Rodriguez JB.. (2013) Design, synthesis and biological evaluation of WC-9 analogs as antiparasitic agents., 69 [PMID:24090919] [10.1016/j.ejmech.2013.09.009] |
12. Chao MN, Storey M, Li C, Rodríguez MG, Di Salvo F, Szajnman SH, Moreno SNJ, Docampo R, Rodriguez JB.. (2017) Selenium-containing analogues of WC-9 are extremely potent inhibitors of Trypanosoma cruzi proliferation., 25 (24): [PMID:29107437] [10.1016/j.bmc.2017.10.016] |
13. Wu RZ, Zhou HY, Song JF, Xia QH, Hu W, Mou XD, Li X.. (2021) Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure-Activity Relationship Investigations., 64 (24.0): [PMID:34894691] [10.1021/acs.jmedchem.1c01569] |
Source(1):